Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCCAP.L Regulatory News (CCAP)

  • There is currently no data for CCAP

Interim Management Statement

12 Jul 2013 07:00

RNS Number : 1606J
Charlemagne Capital Limited
12 July 2013
 



12 July 2013

 

 

Interim Management Statement for the Six Months Ended 30 June 2013

 

 

Charlemagne Capital Limited ("Charlemagne" or the "Group") sets out below the key Revenue items and Assets under Management ("AuM") for the first six months of its current financial year.It is expected that the interim financial results will be announced on 17 September 2013.

 

Key highlights and Group AuM

 

§ As at 30 June 2013, Group AuM were US$2.4 billion, down by 8.1% since 1 January 2013;

 

§ Net management fees of US$11.9 million, up 10.2% on the previous six months;

 

·; The Group remains well-capitalised with a strong and liquid balance sheet; and

 

·; Strong relative performance in key investment strategies.

 

 

The table below sets out the Group's AuM as at 30 June 2013 and the movements experienced in each product range in the period since 1 January 2013.

 

01-Jan-13

Net Subscriptions

Net Performance

30-Jun-13

Movement In

AuM (US$m)

(US$m)

(%)

(US$m)

(%)

AuM (US$m)

Period (%)

Magna

364

86

23.6

(30)

(7.4)

420

15.4

OCCO

597

(36)

(6.0)

25

4.3

586

(1.8)

Institutional

1,526

(113)

(7.4)

(125)

(8.5)

1,288

(15.6)

Specialist

145

(17)

(11.7)

(4)

(2.9)

124

(14.5)

Total

2,632

(80)

(3.0)

(134)

(5.2)

2,418

(8.1)

 

Notes:

Closing AuM is stated as including all subscription and redemption orders received for the relevant funds as at the close of the period but not processed until the first dealing date of the following period.

 

Unaudited revenue numbers for the six months ended 30 June 2013

 

Net management fees receivable were US$11.9 million compared with US$10.8 million for the previous six months and US$9.7 million for the comparable period of 2012, reflecting the higher average AuM over the period of US$2.6 billion compared with US$2.4 billion in 2012 and a small increase in net margin arising from the greater proportion of OCCO higher fee classes that have been present for the full period. OCCO management fees, which are subject to a minority interest, account for nearly 44% of total net fee income during the period.

 

Crystallised performance fees were US$0.5 million compared with US$0.9 million for the comparative period in 2012. Accruing performance fees1 for 2013 which have not crystallised were US$5.9 million, principally from OCCO, compared with US$3.5 million as at the same date in 2012.

 

 

_________________________________________________________________________

1Performance fees accrue throughout the reporting period in the accounts of each relevant fund. It is the group's accounting policy only to recognise such revenues as they crystallise at the year-end date of the fund or, in certain cases, on redemption. Levels of accrued performance fees at any particular time should not be seen as necessarily indicative of the eventual crystallised figures, especially in periods of above average market volatility.

 

Dividend

 

In the absence of unforeseen circumstances, the Group intends to declare an interim dividend in respect of the six months to 30 June 2013. Further details will be provided in the interim results announcement planned for 17 September 2013.

 

Summary

 

Emerging markets have returned a negative performance over the period with the greatest falls in value occurring in June, when the MSCI Emerging markets index was down by 6.4% for the month resulting in a 9.6% ( in US$) drop over the full half year.

 

Over the period, the relative performance of Charlemagne's key equity strategies has been strong, with seven of the nine Magna sub-funds in the top half of their FactSet Morningstar peer group. Notably, theMagna Emerging Markets Dividend Fund, which has a full three year track record as of June 2013, has achieved first quartile performance over all periods since inception and has outperformed the MSCI EM index by 7.6% for the year to date with lower volatility than the index.

 

The positive net inflows into the Magna funds over the first half of the year are predominantly due to subscriptions into the Magna Emerging Markets Dividend Fund. The institutional business benefitted from the acquisition of a new US$45 million Eastern European mandate and US$60 million from existing mandates. However a partial asset reallocation from a long standing mandate, together with outflows from sub advisory business caused the overall net flows to be negative in this category. The OCCO Eastern European Fund also suffered net outflows as some investors reassessed their exposure to the asset class.

 

Outlook

 

In the last quarter of 2012, emerging markets began to outperform developed markets after a period of two years when they had lagged. Inflows returned to the asset class and the outlook was optimistic. The outperformance has reversed in 2013 as not only have emerging markets produced negative returns, but they have also again underperformed developed markets. Momentum has stalled as investors have reassessed asset allocations and industry flows have been negative. Despite strong relative performance our asset values have consequently fallen over the period. Although the Group remains profitable overall in the year to date, an increase in AuM is required in order to ensure sustainable profits on a recurring management fee basis. Under current circumstances, the generation of performance fees during the remainder of the year will be a significant factor in determining full year profit levels. We are reviewing the cost base but are committed to preserving the necessary infrastructure required to service our investors and for future expansion.

 

We believe that, although markets will remain volatile now that the issue of reduced Central Bank support to liquidity is out in the open, there are still reasons for a positive outlook. Equity markets have overreacted and have quickly over discounted a worst possible outcome. Deflationary forces are still such that meaningful interest rate hikes are a long way off and valuations are sufficiently below average to suggest returns from such levels should typically be strong over subsequent 12-18 month periods.

 

 

Enquiries:

 

Charlemagne Capital

 

Jayne Sutcliffe, Chief Executive

Tel. 020 7518 2100

Lloyd Jones, Finance Director

Tel. 01624 640200

 

 

N+1 Singer

+44 020 7496 3000

Jonny Franklin-Adams

Nick Donovan

 

 

 

Smithfield Consultants

Tel. 020 7360 4900

John Kiely

 

 

 

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IMSKMGMNKMLGFZM
Date   Source Headline
20th Jan 20219:05 amRNSSecond Price Monitoring Extn
20th Jan 20219:00 amRNSPrice Monitoring Extension
18th Jan 202110:00 amRNSIssue of Equity and Total Voting Rights
12th Jan 20218:22 amRNSTR-1: Notification of major holdings
11th Jan 20214:35 pmRNSPrice Monitoring Extension
11th Jan 202111:31 amRNSIssue of Equity and Total Voting Rights
11th Jan 20219:00 amRNSTR-1: Notification of major holdings
11th Jan 20217:00 amRNSTR-1: Notification of major holdings
7th Jan 20219:05 amRNSSecond Price Monitoring Extn
7th Jan 20219:00 amRNSPrice Monitoring Extension
6th Jan 20215:32 pmRNSTR-1: Notification of major holdings
2nd Dec 20202:06 pmRNSSecond Price Monitoring Extn
2nd Dec 20202:00 pmRNSPrice Monitoring Extension
20th Nov 20209:05 amRNSSecond Price Monitoring Extn
20th Nov 20209:00 amRNSPrice Monitoring Extension
18th Nov 20207:00 amRNSTR-1: Notification of major holdings
19th Oct 20202:41 pmRNSWarrant Update
7th Oct 20202:05 pmRNSSecond Price Monitoring Extn
7th Oct 20202:00 pmRNSPrice Monitoring Extension
6th Oct 20203:08 pmRNSNew Website
14th Dec 20164:01 pmRNSScheme Effective
13th Dec 20164:15 pmRNSCourt Sanction of Scheme
13th Dec 20167:30 amRNSSuspension - Charlemagne Capital Limited
12th Dec 20168:05 amRNSDocument re: Charlemagne Capital
12th Dec 20168:01 amRNSSuspension of Dealings and Transfers
9th Dec 201610:55 amRNSDocument re: Charlemagne Capital
8th Dec 20161:22 pmRNSConfirmation of Regulatory Clearance
8th Dec 201611:36 amRNSDocument re: Charlemagne Capital
7th Dec 20164:25 pmRNSDocument re: Charlemagne Capital
7th Dec 20164:21 pmRNSDocument re: Charlemagne Capital
2nd Dec 20165:19 pmRNSResults of the Court Meeting
10th Nov 20167:00 amRNSScheme Circular
14th Oct 20163:05 pmRNSDocument re: Charlemagne Capital
12th Oct 20167:00 amRNSQ3 2016 AUM Update
3rd Oct 20163:30 pmRNSTR-1: Notification of Major Interest in Shares
30th Sep 20163:01 pmRNSOPD - Charlemagne Capital - Replacement
30th Sep 20162:50 pmRNSDoc re. Charlemagne Capital
30th Sep 20167:00 amRNSForm 8 (OPD) Charlemagne Capital plc
30th Sep 20167:00 amRNSRecommended Cash Offer for Charlemagne
30th Sep 20167:00 amRNSHalf Yearly Report
19th Sep 201611:01 amRNSTR-1: Notification of Major Interest in Shares
14th Jul 20167:00 amRNSTrading Statement
27th Jun 20164:40 pmRNSSecond Price Monitoring Extn
27th Jun 20164:35 pmRNSPrice Monitoring Extension
17th Jun 20161:56 pmRNSResult of AGM
20th May 20164:38 pmRNSAnnual Report and Notice of AGM
28th Apr 20161:22 pmRNSTR-1: Notification of Major Interest in Shares
15th Apr 201610:08 amRNSTR-1: Notification of Major Interest in Shares
11th Apr 20167:00 amRNSQ1 2016 AUM Update
24th Mar 20169:16 amRNSTR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.